Twist Bioscience Corporation · NASDAQ:TWST
Leproust Emily M. sold 16,470 Twist Bioscience Corporation shares (Form 4)
Traded May 28, 2026 · Filed Jun 1, 2026
On May 28, 2026, Leproust Emily M. (Director, Chief Executive Officer) sold 16,470 Twist Bioscience Corporation shares at an average US$67.91 for US$1.12M under a trading plan, leaving 846,872 shares. Filed Jun 1, 2026 (Form 4).
- Sold
- 16,470 shares
- Price
- US$67.91 average (US$65.33 to US$68.61)
- Value
- US$1.12M
- Holding after
- 846,872 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | Option exercise | 16,470 | US$8.82 | 863,342 | Direct |
| May 28, 2026 | Common Stock | Sale | 1,482 | US$65.33 | 861,860 | Direct |
| May 28, 2026 | Common Stock | Sale | 900 | US$66.85 | 860,960 | Direct |
| May 28, 2026 | Common Stock | Sale | 7,623 | US$67.95 | 853,337 | Direct |
| May 28, 2026 | Common Stock | Sale | 6,465 | US$68.61 | 846,872 | Direct |
Source
Related
- Twist Bioscience Corporation
- Leproust Emily M.
- Twist Bioscience Corporation shareholders
- Form 4 · Leproust Emily M. · Oct 7, 2026
- Form 4 · Leproust Emily M. · Oct 5, 2026
- Form 4 · Leproust Emily M. · Sep 25, 2026
- Form 4 · Leproust Emily M. · Sep 23, 2026
- Form 4 · Leproust Emily M. · Sep 21, 2026
- Form 4 · Laponis Adam · Oct 13, 2026
- Form 4 · Green Paula · Oct 5, 2026
- Form 4 · Laponis Adam · Oct 5, 2026
- Form 4 · Finn Patrick John · Oct 5, 2026
- Form 4 · Werner Robert F. · Oct 5, 2026